Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene Therapy in Oncology
1.2 Key Market Segments
1.2.1 Gene Therapy in Oncology Segment by Type
1.2.2 Gene Therapy in Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene Therapy in Oncology Market Overview
2.1 Global Market Overview
2.1.1 Global Gene Therapy in Oncology Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene Therapy in Oncology Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene Therapy in Oncology Market Competitive Landscape
3.1 Global Gene Therapy in Oncology Sales by Manufacturers (2019-2024)
3.2 Global Gene Therapy in Oncology Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene Therapy in Oncology Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene Therapy in Oncology Sales Sites, Area Served, Product Type
3.6 Gene Therapy in Oncology Market Competitive Situation and Trends
3.6.1 Gene Therapy in Oncology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Therapy in Oncology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gene Therapy in Oncology Industry Chain Analysis
4.1 Gene Therapy in Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene Therapy in Oncology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gene Therapy in Oncology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy in Oncology Sales Market Share by Type (2019-2024)
6.3 Global Gene Therapy in Oncology Market Size Market Share by Type (2019-2024)
6.4 Global Gene Therapy in Oncology Price by Type (2019-2024)
7 Gene Therapy in Oncology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy in Oncology Market Sales by Application (2019-2024)
7.3 Global Gene Therapy in Oncology Market Size (M USD) by Application (2019-2024)
7.4 Global Gene Therapy in Oncology Sales Growth Rate by Application (2019-2024)
8 Gene Therapy in Oncology Market Segmentation by Region
8.1 Global Gene Therapy in Oncology Sales by Region
8.1.1 Global Gene Therapy in Oncology Sales by Region
8.1.2 Global Gene Therapy in Oncology Sales Market Share by Region
8.2 North America
8.2.1 North America Gene Therapy in Oncology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Therapy in Oncology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Therapy in Oncology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Therapy in Oncology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Therapy in Oncology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Gene Therapy in Oncology Basic Information
9.1.2 Bristol-Myers Squibb Gene Therapy in Oncology Product Overview
9.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Product Market Performance
9.1.4 Bristol-Myers Squibb Business Overview
9.1.5 Bristol-Myers Squibb Gene Therapy in Oncology SWOT Analysis
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Cold Genesys
9.2.1 Cold Genesys Gene Therapy in Oncology Basic Information
9.2.2 Cold Genesys Gene Therapy in Oncology Product Overview
9.2.3 Cold Genesys Gene Therapy in Oncology Product Market Performance
9.2.4 Cold Genesys Business Overview
9.2.5 Cold Genesys Gene Therapy in Oncology SWOT Analysis
9.2.6 Cold Genesys Recent Developments
9.3 Advantagene
9.3.1 Advantagene Gene Therapy in Oncology Basic Information
9.3.2 Advantagene Gene Therapy in Oncology Product Overview
9.3.3 Advantagene Gene Therapy in Oncology Product Market Performance
9.3.4 Advantagene Gene Therapy in Oncology SWOT Analysis
9.3.5 Advantagene Business Overview
9.3.6 Advantagene Recent Developments
9.4 Amgen
9.4.1 Amgen Gene Therapy in Oncology Basic Information
9.4.2 Amgen Gene Therapy in Oncology Product Overview
9.4.3 Amgen Gene Therapy in Oncology Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Gene Therapy in Oncology Basic Information
9.5.2 AstraZeneca Gene Therapy in Oncology Product Overview
9.5.3 AstraZeneca Gene Therapy in Oncology Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Bio-Path Holdings
9.6.1 Bio-Path Holdings Gene Therapy in Oncology Basic Information
9.6.2 Bio-Path Holdings Gene Therapy in Oncology Product Overview
9.6.3 Bio-Path Holdings Gene Therapy in Oncology Product Market Performance
9.6.4 Bio-Path Holdings Business Overview
9.6.5 Bio-Path Holdings Recent Developments
9.7 CRISPR Therapeutics
9.7.1 CRISPR Therapeutics Gene Therapy in Oncology Basic Information
9.7.2 CRISPR Therapeutics Gene Therapy in Oncology Product Overview
9.7.3 CRISPR Therapeutics Gene Therapy in Oncology Product Market Performance
9.7.4 CRISPR Therapeutics Business Overview
9.7.5 CRISPR Therapeutics Recent Developments
9.8 Editas Medicine
9.8.1 Editas Medicine Gene Therapy in Oncology Basic Information
9.8.2 Editas Medicine Gene Therapy in Oncology Product Overview
9.8.3 Editas Medicine Gene Therapy in Oncology Product Market Performance
9.8.4 Editas Medicine Business Overview
9.8.5 Editas Medicine Recent Developments
9.9 Geron Corp
9.9.1 Geron Corp Gene Therapy in Oncology Basic Information
9.9.2 Geron Corp Gene Therapy in Oncology Product Overview
9.9.3 Geron Corp Gene Therapy in Oncology Product Market Performance
9.9.4 Geron Corp Business Overview
9.9.5 Geron Corp Recent Developments
9.10 Idera Pharmaceuticals
9.10.1 Idera Pharmaceuticals Gene Therapy in Oncology Basic Information
9.10.2 Idera Pharmaceuticals Gene Therapy in Oncology Product Overview
9.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Product Market Performance
9.10.4 Idera Pharmaceuticals Business Overview
9.10.5 Idera Pharmaceuticals Recent Developments
9.11 Intellia Therapeutics
9.11.1 Intellia Therapeutics Gene Therapy in Oncology Basic Information
9.11.2 Intellia Therapeutics Gene Therapy in Oncology Product Overview
9.11.3 Intellia Therapeutics Gene Therapy in Oncology Product Market Performance
9.11.4 Intellia Therapeutics Business Overview
9.11.5 Intellia Therapeutics Recent Developments
9.12 Johnson and Johnson
9.12.1 Johnson and Johnson Gene Therapy in Oncology Basic Information
9.12.2 Johnson and Johnson Gene Therapy in Oncology Product Overview
9.12.3 Johnson and Johnson Gene Therapy in Oncology Product Market Performance
9.12.4 Johnson and Johnson Business Overview
9.12.5 Johnson and Johnson Recent Developments
9.13 Marsala Biotech
9.13.1 Marsala Biotech Gene Therapy in Oncology Basic Information
9.13.2 Marsala Biotech Gene Therapy in Oncology Product Overview
9.13.3 Marsala Biotech Gene Therapy in Oncology Product Market Performance
9.13.4 Marsala Biotech Business Overview
9.13.5 Marsala Biotech Recent Developments
9.14 Merck
9.14.1 Merck Gene Therapy in Oncology Basic Information
9.14.2 Merck Gene Therapy in Oncology Product Overview
9.14.3 Merck Gene Therapy in Oncology Product Market Performance
9.14.4 Merck Business Overview
9.14.5 Merck Recent Developments
9.15 Mologen AG
9.15.1 Mologen AG Gene Therapy in Oncology Basic Information
9.15.2 Mologen AG Gene Therapy in Oncology Product Overview
9.15.3 Mologen AG Gene Therapy in Oncology Product Market Performance
9.15.4 Mologen AG Business Overview
9.15.5 Mologen AG Recent Developments
9.16 Oncolytics Biotech
9.16.1 Oncolytics Biotech Gene Therapy in Oncology Basic Information
9.16.2 Oncolytics Biotech Gene Therapy in Oncology Product Overview
9.16.3 Oncolytics Biotech Gene Therapy in Oncology Product Market Performance
9.16.4 Oncolytics Biotech Business Overview
9.16.5 Oncolytics Biotech Recent Developments
9.17 Oncosec
9.17.1 Oncosec Gene Therapy in Oncology Basic Information
9.17.2 Oncosec Gene Therapy in Oncology Product Overview
9.17.3 Oncosec Gene Therapy in Oncology Product Market Performance
9.17.4 Oncosec Business Overview
9.17.5 Oncosec Recent Developments
9.18 Oncotelic
9.18.1 Oncotelic Gene Therapy in Oncology Basic Information
9.18.2 Oncotelic Gene Therapy in Oncology Product Overview
9.18.3 Oncotelic Gene Therapy in Oncology Product Market Performance
9.18.4 Oncotelic Business Overview
9.18.5 Oncotelic Recent Developments
9.19 Shenzhen SiBiono GeneTech
9.19.1 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Basic Information
9.19.2 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Overview
9.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Market Performance
9.19.4 Shenzhen SiBiono GeneTech Business Overview
9.19.5 Shenzhen SiBiono GeneTech Recent Developments
9.20 Sillajen Biotherapeutics
9.20.1 Sillajen Biotherapeutics Gene Therapy in Oncology Basic Information
9.20.2 Sillajen Biotherapeutics Gene Therapy in Oncology Product Overview
9.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Product Market Performance
9.20.4 Sillajen Biotherapeutics Business Overview
9.20.5 Sillajen Biotherapeutics Recent Developments
9.21 Tocagen
9.21.1 Tocagen Gene Therapy in Oncology Basic Information
9.21.2 Tocagen Gene Therapy in Oncology Product Overview
9.21.3 Tocagen Gene Therapy in Oncology Product Market Performance
9.21.4 Tocagen Business Overview
9.21.5 Tocagen Recent Developments
9.22 UniQure
9.22.1 UniQure Gene Therapy in Oncology Basic Information
9.22.2 UniQure Gene Therapy in Oncology Product Overview
9.22.3 UniQure Gene Therapy in Oncology Product Market Performance
9.22.4 UniQure Business Overview
9.22.5 UniQure Recent Developments
9.23 Ziopharm Oncology
9.23.1 Ziopharm Oncology Gene Therapy in Oncology Basic Information
9.23.2 Ziopharm Oncology Gene Therapy in Oncology Product Overview
9.23.3 Ziopharm Oncology Gene Therapy in Oncology Product Market Performance
9.23.4 Ziopharm Oncology Business Overview
9.23.5 Ziopharm Oncology Recent Developments
10 Gene Therapy in Oncology Market Forecast by Region
10.1 Global Gene Therapy in Oncology Market Size Forecast
10.2 Global Gene Therapy in Oncology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Therapy in Oncology Market Size Forecast by Country
10.2.3 Asia Pacific Gene Therapy in Oncology Market Size Forecast by Region
10.2.4 South America Gene Therapy in Oncology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene Therapy in Oncology by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gene Therapy in Oncology Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene Therapy in Oncology by Type (2025-2030)
11.1.2 Global Gene Therapy in Oncology Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene Therapy in Oncology by Type (2025-2030)
11.2 Global Gene Therapy in Oncology Market Forecast by Application (2025-2030)
11.2.1 Global Gene Therapy in Oncology Sales (K Units) Forecast by Application
11.2.2 Global Gene Therapy in Oncology Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
